Patient Portal Market

Executive Summary

Patient Portal Market was valued at US $2.88 billion in 2021 and is projected to grow at 20.00% CAGR over the forecast period to reach US $8.60 billion by 2027. Patient Portal Market represented US $0.88 billion opportunity over 2019-2021 and estimated to create US $5.72 billion opportunity in 2027 over 2021.

Patient Portal from Consainsights analyses the Patient Portal Market in the Life Sciences industry over the forecast period to 2027.

Patient Portal research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Patient Portal segmentation includes Type, Delivery Mode, End User, Region and Geography.

Based on the Type, the Patient Portal analysis covers Integrated Patient Portals, Standalone Patient Portals.

In Type segment, Integrated Patient Portals segment has highest cagr growth of 17.59%.

Based on the Delivery Mode, the Patient Portal analysis covers Web-Based Delivery, Cloud-Based Delivery.

In Delivery Mode segment, Web-Based Delivery segment has highest cagr growth of 17.59%.

Based on the End User, the Patient Portal analysis covers Providers, Payers, Pharmacies, Others.

In End User segment, Providers segment has highest cagr growth of 17.59%.

Based on the Region, the Patient Portal analysis covers North America, Europe, Asia-Pacific (APAC), Rest of World (RoW).

In Region segment, North America segment has highest cagr growth of 17.59%.

Based on the region, the Patient Portal analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Allscripts Healthcare Solutions, Inc., Mckesson Corporation, Athenahealth, Cerner Corporation, Eclinicalworks, Curemd, Nextgen Healthcare Information Systems,LLC (Subsidiary of Quality Systems, Inc.), Greenway Health,LLC, Medfusion, Inc., Epic Corporation, Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Integrated Patient Portals segment has the highest revenue of US $1.74 billion and is expected to grow at CAGR of 17.59% by 2027 Integrated Patient Portals segment has highest cagr growth of 17.59%.

Integrated Patient Portals

Integrated Patient Portals segment was valued at US $1.21 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $5.20 billion by 2027. Integrated Patient Portals segment represented US $0.53 billion opportunity over 2019-2021 and estimated to create US $3.46 billion opportunity in 2027 over 2021.

Standalone Patient Portals

Standalone Patient Portals segment was valued at US $0.79 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $3.40 billion by 2027. Standalone Patient Portals segment represented US $0.35 billion opportunity over 2019-2021 and estimated to create US $2.26 billion opportunity in 2027 over 2021.

Delivery Mode

Introduction

In 2021, Web-Based Delivery segment has the highest revenue of US $2.51 billion and is expected to grow at CAGR of 17.59% by 2027 Web-Based Delivery segment has highest cagr growth of 17.59%.

Web-Based Delivery

Web-Based Delivery segment was valued at US $1.74 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $7.49 billion by 2027. Web-Based Delivery segment represented US $0.77 billion opportunity over 2019-2021 and estimated to create US $4.98 billion opportunity in 2027 over 2021.

Cloud-Based Delivery

Cloud-Based Delivery segment was valued at US $0.26 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $1.11 billion by 2027. Cloud-Based Delivery segment represented US $0.11 billion opportunity over 2019-2021 and estimated to create US $0.74 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Providers segment has the highest revenue of US $1.24 billion and is expected to grow at CAGR of 17.59% by 2027 Providers segment has highest cagr growth of 17.59%.

Providers

Providers segment was valued at US $0.86 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $3.71 billion by 2027. Providers segment represented US $0.38 billion opportunity over 2019-2021 and estimated to create US $2.47 billion opportunity in 2027 over 2021.

Payers

Payers segment was valued at US $0.77 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $3.33 billion by 2027. Payers segment represented US $0.34 billion opportunity over 2019-2021 and estimated to create US $2.22 billion opportunity in 2027 over 2021.

Pharmacies

Pharmacies segment was valued at US $0.21 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $0.90 billion by 2027. Pharmacies segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.60 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $0.15 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $0.67 billion by 2027. Others segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.44 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $1.43 billion and is expected to grow at CAGR of 17.59% by 2027 North America segment has highest cagr growth of 17.59%.

North America

North America segment was valued at US $0.99 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $4.27 billion by 2027. North America segment represented US $0.44 billion opportunity over 2019-2021 and estimated to create US $2.84 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $0.45 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $1.95 billion by 2027. Europe segment represented US $0.20 billion opportunity over 2019-2021 and estimated to create US $1.30 billion opportunity in 2027 over 2021.

Asia-Pacific (APAC)

Asia-Pacific (APAC) segment was valued at US $0.43 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $1.87 billion by 2027. Asia-Pacific (APAC) segment represented US $0.19 billion opportunity over 2019-2021 and estimated to create US $1.24 billion opportunity in 2027 over 2021.

Rest of World (RoW)

Rest of World (RoW) segment was valued at US $0.12 billion in 2019 and is projected to grow at 17.59% CAGR over the forecast period to reach US $0.51 billion by 2027. Rest of World (RoW) segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.34 billion opportunity in 2027 over 2021.